Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
  • Legit.Health Plus Version 1.1.0.1
  • Legit.Health Utilities
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • Pricing
  • Public tenders
    • AQUAS-2025-42
    • Aragón SAN_DGSDI_2026_MN01
      • Requirements
      • Submission
      • Aragón SAN_DGSDI_2026_MN01
    • 623185-2025
  • Public tenders
  • Aragón SAN_DGSDI_2026_MN01
  • Aragón SAN_DGSDI_2026_MN01

Aragón SAN_DGSDI_2026_MN01

Overview​

Public tender (contrato menor) from the Gobierno de Aragón - Consejería de Sanidad, Dirección General de Salud Digital e Infraestructuras (DGSDI).

This tender is tailored for Legit.Health. It is a minor contract awarded by exclusivity (art. 168.a.2 LCSP), meaning only one provider can meet the technical requirements. The exclusivity justification documents were prepared by Legit.Health itself.

  • Expediente: SAN_DGSDI_2026_MN01
  • Subject: AI-based digital solution for dermatological lesion diagnosis and severity measurement + temporary corporate use license
  • Value: 14,995.00 EUR (18,143.95 EUR with VAT)
  • Duration: 4.5 months from contract formalization
  • Procedure: Contrato menor de servicios (art. 118 LCSP)
  • Contracting entity: Gobierno de Aragón (CIF: S5011001D), Departamento de Sanidad
  • Destination unit: Dirección General de Salud Digital e Infraestructuras

Source documents​

documento-de-requisitos-contrato-menor.pdf​

Official requirements document issued by the DGSDI (21 pages, signed 19/02/2026 by Joaquín Velilla Moliner, Director General de Salud Digital e Infraestructuras).

Contents:

  • Introduction and legal basis (Decreto 39/2024)
  • Contract object: AI platform for dermatology diagnosis + severity measurement + corporate license (up to 10,000 reports, up to 3 images per report, 6 months)
  • Functional requirements: image quality analysis, differential diagnosis, automated severity measurement, corporate integration (HCE + mobile app), support/training, regulatory compliance (RGPD, LOPDGDD, ENS, MDR CE marking), administration/monitoring, portability/scalability
  • Differential diagnosis capabilities (section 4.1): pathology recognition, probabilistic analysis, alarm signs, additional data incorporation, structured reports, traceability
  • Integration capabilities (section 4.2): HCE and mobile app integration, SSO, SOA architecture, REST/JSON + SOAP protocols
  • Technology environment (section 5): Apache HTTP Server, JBoss J2EE, Oracle 19c, VMWare; JSON API integration; iframe integration
  • Planning (section 6): setup phase + return phase
  • Contract conditions (section 7): value, duration, billing (FACE/DIR3), conformity, confidentiality/security
  • Technology transfer (section 8)
  • Offer structure (section 9): technical offer (APTA/NO APTA) + economic offer
  • Annex I: Economic offer template
  • Annex II: Data processing agreement (encargado del tratamiento)

informe-exclusividad-v1-borrador.pdf​

First version of Legit.Health's exclusivity justification report (5 pages, dated 11/02/2026, NOT digitally signed). This is a draft/earlier version.

Claims compliance with:

  1. CE marking as medical device
  2. Coverage of 280 pathologies (301 API output classes, ICD-11 coded)
  3. Automated severity scales (APASI, ASCORAD, AUAS, ALADIN, AIHS4, EASI, IGA, GAGS, DLQI)
  4. DIQA (Dermatology Image Quality Assessment) system

References annexes (I-IV) with certificates and publications.

informe-exclusividad-v2-firmado.pdf​

Updated and digitally signed version of the exclusivity justification report (3 pages, dated 17/02/2026, digitally signed by Sheyla Andina Aguilar Robles).

Key differences from v1:

  • Updated pathology coverage: 850 CIE-11 conditions grouped into 346 visible pathologies (vs. 280/301 in v1)
  • Mentions additional indices: malignancy suspicion, urgency/referral need
  • Removes DLQI from the automated scales list
  • More concise format (no annexes section, supporting docs referenced inline)
  • Digitally signed (the version submitted to Aragón)

Directory structure​

Following the pattern from aquas-2025-42/, adapted for a contrato menor (simpler than an open bid):

aragon-san-dgsdi-2026-mn01/
_category_.json
CLAUDE.md # This file
documento-de-requisitos-contrato-menor.pdf # Official tender requirements (source PDF)
informe-exclusividad-v1-borrador.pdf # Exclusivity report draft (11/02/2026)
informe-exclusividad-v2-firmado.pdf # Exclusivity report signed (17/02/2026)
requirements/
_category_.json
index.mdx # Full requirements analysis
submission/
_category_.json
oferta-tecnica.mdx # Technical offer (sections 1.1-1.6)
oferta-economica.mdx # Economic offer (Annex I)

Key differences from AQUAS-2025-42​

  • Contrato menor (minor contract, <15,000 EUR excl. VAT) vs. open competitive bid (1.2M EUR)
  • Exclusivity-based award (no competition) vs. scored evaluation with multiple envelopes
  • Single requirements document vs. separate PPT + PCAP + QC
  • APTA/NO APTA technical evaluation (pass/fail) vs. scored criteria (68 points technical + 32 automatic)
  • No administrative envelope (Sobre A) needed - just technical offer + economic offer
  • No appeals process expected (the tender is designed for us)
Previous
Oferta económica
Next
623185-2025
  • Overview
  • Source documents
    • documento-de-requisitos-contrato-menor.pdf
    • informe-exclusividad-v1-borrador.pdf
    • informe-exclusividad-v2-firmado.pdf
  • Directory structure
  • Key differences from AQUAS-2025-42
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)